Clinical Trials Browser

Phase 4 × suvorexant × 30 days × Clear all

NCT06162663 2026-02-27

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Phase 4 Terminated

Breast Neoplasms, Sleep Initiation and Maintenance Disorders